PropThink: QCOR Strengthening On Positive Clinical Data To Be Presented Soon

[ACN Newswire] – By David MoskowitzQuestcor Pharmaceuticals (NASDAQ:QCOR), to no one’s surprise, remains volatile. Notably, the stock hit an intraday low of $17.60 on October 5th, and closed Thursday 19.5% higher than … more

View todays social media effects on QCOR

View the latest stocks trending across Twitter. Click to view dashboard